Prokinetics in SIBO & Motility Disorders

Size: px
Start display at page:

Download "Prokinetics in SIBO & Motility Disorders"

Transcription

1 Prokinetics in SIBO & Motility Disorders Allison Siebecker ND, MSOM, LAc Source: boundless.com Motility Bootcamp, July 2016 AANP, Salt Lake City Ut Prokinetics: Definition Increase transit/motility in GI tract Improve coordination of GI movement Increase LES tone, relax pylorus v Amplify & coordinate GI muscular contractions Can have different sites of action: upper or lower GI Vs Laxative = stimulate BM s, loosen stool Pk can be laxative but often aren t, esp at low dose Pk can be used w/diarrhea to (+) upper GI motility, esp at lower dose Key Points Not all prokinetics are unsafe Side Effects/Reactions are common 1

2 Adapted from Scarpignato 98 and 12, with Ottillinger 13 Prucalopride no no yes yes few Iberogast yes yes yes few Prucalopride helps: nausea, bloating, pain, constipation (Emmanuel 12, Diederen 15) Iberogast helps: nausea, GERD, bloating, cramping/pain, constipation, diarrhea (Ottillinger 13) Prokinetics: Mechanisms of Action Muscarinic Acetylcholine Receptor Agonist: M (+) Acetylcholinesterase Inhibitor: ACh (-) Dopamine 2 Receptor Antagonist: D2(-) Seratonin 3 Receptor Antagonist: 5-HT3 (-) Seratonin 4 Receptor Agonist: 5-HT4 (+) = (+) ACh Motilin Receptor Agonist Cholecystokinin A Receptor Antagonist: CCK-A (-) Opioid Receptor Antagonist Adapted from Scarpignato 98 with Manabe 10, Simmen 06 M3 Opioid receptor receptor agonism antagonism Prucalopride no no yes no no no no Iberogast no yes yes no no yes yes Low Dose Naltrexone no no no no no no yes 2

3 Prokinetic Usage 1. Symptom Relief in Motility or Functional GI Disorders Dosed: tid before meals. Or after/in between meals and first a.m. for GERD, dyspepsia/gastroparesis (sx after meals), bloating v to move food, acid, gas out of St/SI Dosed: qd may enough for constipation depending on Pk Dose: standard Pk dose 2. Prevention of SIBO Relapse (maintenance of remission) Dosed: before bed v to (+) MMC overnight Dose: low dose to prevent return of sx Prokinetics Usage 1. Symptom Relief TID (or QD constipation) Regular dose 2. SIBO Relapse Prevention HS Low Dose Prokinetic Dose Motility, FGI Disorders Sx Relief Pharmaceutical Low Dose Erythromycin (LDE) mg tid-qid Prucalopride 1-4mg qd or 1mg bid-tid Low Dose Naltrexone (LDN) mg hs or bid 2.5mg- diarrhea, 4.5mg- constipation Herbal Iberogast 20 drops tid or PRN Ginger 500mg tid, 1000mg bid MP 2-3caps bid-tid (5Htp, Acetyl L Carnitine, Ginger, Vit C, B6) 3

4 Prokinetic Dose SIBO Relapse Prevention Pharmaceutical Low Dose Erythromycin (LDE) mg at bedtime (hs) Low Dose Prucalopride (LDP) 0.5 mg hs (up to 2 mg if needed) Low Dose Naltrexone (LDN) mg hs or bid 2.5mg- diarrhea, 4.5mg- constipation Herbal Iberogast drops hs Ginger 1000mg hs MP 2-3caps hs or hs & a.m. (5Htp, Acetyl L Carnitine, Ginger, Vit C, B6) Erythromycin & Prucalopride LDE No/weak Abx activity at low dose. Standard Tx for Gastroparesis Delayed SIBO relapse by 2.5 mo (Pimentel 09) SE vary. Tolerance possible. Prolong QT waves. P450 3A4 interactions Prucalopride Safer/stronger alternative to Tegaserod which delayed SIBO relapse by 6mo (Pimentel 09) Dr P thinks may help heal MMC over time. 1 st choice of many GE/most effective Pk SE: h/a, urinary urge, temporary diarr, varied. Tolerance possible. Obtained through Canadadrugs.com. Available in US soon. LDN & Iberogast LDN 68% success for SIBO Prevention, 38% failure (Ploesser 10) v Doesn t work as Pk (not strong enough) in many (Combine w/other Pk) SE: varied, sleep disturbance- titrate up to help avoid Also used for inflammation, depression, Auto Immune dz (=PI-IBS) Iberogast 75-85% success= IBS, Significant Sx improvement= Dyspepsia (Ottillinger) v Miracle for nausea More effective vs metoclopramide, similar vs cisapride = Dyspepsia SE: 0.04%. Safe for long term use, pregnancy, children 4

5 Ginger Ginger & MP MoA: + gastric emptying/mmc, M Rec (+), 5-HT3 (-) (Micklefield 99, Hu 11, Haniadka 13, Wu 08 Thompson 14) SE: 28% GERD/Ginger Burn (Thompson 14) helped by drinking water MP (no studies) Ginger, 5HTP, acetyl L-carnitine, Vit C, B6 MoA: saa + extra ACh/Cholinergic SE: GERD, diarrhea (+ LI motility too) Japanese Daikenchuto Motilin agonist + lots more (Tominaga 13, Nagano 99, Mochiki 10) Thought to effect distal SI & LI best (Nakaji 11) 190mg/kg/day (Endo 14) or 5g tid before meals Processed Ginger 3-5g + Ginseng 3g + Sichuan Pepper (Zanthoxylum piperitum) 2g Bitter Orange (immature/fructus auranti /Zhi Shi)(poncirus fructus) 5-HT4 (+) (Qiu 11, Jiang 14, Kim 13, Shim 10) ingredient in Chaihu Shugan San Triphala Other Natural Prokinetics mild prokinetic, laxative (Mukherjee 97, Jirankalgikar 12, Tamhane 97) How To Choose Pk v When you need to be sure: choose Pruc or LDE Pruc: need effectiveness, chronic cases, constipation, PI-IBS LDE: chronic/recurrent cases w/o constipation, gastroparesis LDN: inflammation, auto-immunity, depression Iberogast: want natural, broad sx relief, nausea Ginger: nausea/gastroparesis, not w/gerd MP: constipation, depression, not w/gerd v PARQ patient & ask their input 5

6 Pk PARQ: Pro s & Con s Prucalopride: Pro: strongest, safe (no QT/p450), low se, may heal MMC over time. Con: tolerance/se possible, expensive, 3wks to get in mail/not FDA approved Eryth: Pro: studied for SIBO, inexpensive/easily available, low se. Con: tolerance/se possible, long-term low-dose Abx, p450 interactions. Cx: preexist Ht cond (can prolong QT), w/berb (p450) LDN: Pro: anti-inflam, used for AI dz & depression, natural MoA. Con: not strong enough for some (1/3+)(tech not Pk), se: sleep disturbance Iberogast: Pro: natural, well studied as a Pk, broad GI sx relief, safe: kids, preg, lactation, no s.e. s in studies. Con: not strong enough for many, indiv se poss Ginger: Pro: natural, anti-nausea/inflam. Con: se: GERD/ginger burn, tolerance, not strong enough for many MP: Pro: (+)BM s/li motility, anti-depressant/sleep aid Con: (+)BM s/li motility, se: GERD/ginger burn, emotional, sleep, not strong enough for many Start/Duration/Stop Start: Sx Relief- any time Dr Scarp suggests LI purging 1 st to avoid anti-peristalsis (not w/diarrhea pt) Start: SIBO prevention- 1-5 days after tx Important to be on Pk between tx courses to hold gains/prevent relapse Plan ahead: Give the Rx/Pk Plan when Tx is given Duration: Sx- ongoing PRN. SIBO- min 3mo, ongoing for many May be stopped at any time- only risk is relapse of Sx or SIBO Stop: Titrate down slowly, esp w/sibo to catch a relapse Other Motility Considerations Stress Decrease stress/sympathetic: Rushing, worrying Increase parasympathetic: Conscious breaths, Gratitude, Rest Meal Spacing/ Overnight Fast 4-5 hrs between meals, 12 hr overnight fast to optimize MMC Physical Tx/Body work Wurn technique, visceral manipulation, cranial osteopathy 6

7 Pk: Pregnancy, Lactation & Pediatrics Preg & Lact: There are no category listing for the low Rx Pk doses used LDE (Cat B at regular Abx dose) Prucalopride is analogous to US Cat B (at regular 2-4mg dose) Safe: LDN, Iberogast, Ginger (max 2g/d) Peds Doses: LDE 25mg, LDN & Prucalopride 0.01mg/kg, Iberogast gtts, Ginger 250mg 7

The Opportunity: c-ibs and pain relief with confidence YKP10811

The Opportunity: c-ibs and pain relief with confidence YKP10811 The Opportunity: c-ibs and pain relief with confidence YKP10811 1 TABLE OF CONTENTS Profile Summary Clinical Data Mode of Action Pharmacologic Profile Safety and Toxicity Profile ADME Overview vs. Competitors

More information

Gastrointestinal motility modulating drugs include all compounds which have pharmacological

Gastrointestinal motility modulating drugs include all compounds which have pharmacological Pharmacotherapeutics Gastrointestinal Motility Modulating Drugs Oh Young Lee, MD Department of Internal Medicine, Hanyang University College of Medicine E - mail : leeoy@hanyang.ac.kr J Korean Med Assoc

More information

Lincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 1. Instructor: Lisa Shaver, ND, LAc

Lincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 1. Instructor: Lisa Shaver, ND, LAc Lincoln College of Postprofessional, Graduate and Continuing Education Case Presentation 1 Instructor: Lisa Shaver, ND, LAc Faculty and Instructors representing NUHS/Lincoln College of Postprofessional,

More information

Lincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 3. Instructor: Lisa Shaver, ND, LAc

Lincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 3. Instructor: Lisa Shaver, ND, LAc Lincoln College of Postprofessional, Graduate and Continuing Education Case Presentation 3 Instructor: Lisa Shaver, ND, LAc Faculty and Instructors representing NUHS/Lincoln College of Postprofessional,

More information

New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome

New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome Soojong Hong Chae, MD Clinical Assistant Professor Digestive Diseases and Nutrition University of South Florida ROME III Functional dyspepsia

More information

2018 SIBO Dispensary Guide

2018 SIBO Dispensary Guide Dr Nirala Jacobi ND 2018 SIBO Dispensary Guide Version 1.1 08 June 2018 Copyright 2018 The SIBO Doctor Pty Ltd. All rights reserved. Dr Nirala Jacobi ND 2018 SIBO Dispensary Guide The natural treatment

More information

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:

More information

Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI

Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI Clinical Approach to the Patient t with Dyspepsia William D. Chey, MD, FACG Professor of Medicine University of Michigan Prevalence of Endoscopic Findings in Individuals with Dyspepsia Systematic Review

More information

Gastroparesis and other upper GI problems DR ANDREW DAVIES

Gastroparesis and other upper GI problems DR ANDREW DAVIES Gastroparesis and other upper GI problems DR ANDREW DAVIES Outline Gastroparesis Hiccoughs Gastroparesis Gastroparesis Definition: A syndrome of objectively delayed gastric emptying in the absence of mechanical

More information

Primary Management of Irritable Bowel Syndrome

Primary Management of Irritable Bowel Syndrome Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)

More information

SIBO: Clinical Strategies Online Certification Course

SIBO: Clinical Strategies Online Certification Course Source: boundless.com SIBO: Clinical Strategies Online Certification Course Allison Siebecker ND, MSOM, LAc www.siboinfo.com Invivo Clinical May, 2017 Dr. Siebecker 2012-2017 1 Class 2 Diagnosis: Testing

More information

Carminatives IBS C 11/12/10. Partial List of Carminatives and Secondary Benefits. Partial List of Carminatives and Secondary Benefits

Carminatives IBS C 11/12/10. Partial List of Carminatives and Secondary Benefits. Partial List of Carminatives and Secondary Benefits IBS C Individuals experience a range of symptoms in addition to constipation (straining and hard stools) but also report abdominal pain and bloating as particularly troubling. Carminatives Estimated average

More information

DR ALLISON SIEBECKER

DR ALLISON SIEBECKER DR ALLISON SIEBECKER SIBO: Causes, Effects and Treatments Allison Siebecker ND, MSOM, LAc www.siboinfo.com Source: boundless.com SIBO Summit October 7 & 9 2016 Australia Dr. Siebecker 2016 SIBO Definition

More information

Management of Functional Dyspepsia (FD)

Management of Functional Dyspepsia (FD) Management of Functional Dyspepsia (FD) Amy S. Oxentenko, MD, FACG Program Director and Associate Chair, IM Associate Professor of Medicine Mayo Clinic, Rochester Outline Define functional dyspepsia (FD)

More information

Small Intestinal Bacterial Overgrowth: Updates and Clinical Implications. Christine Stubbe, ND, FABNO

Small Intestinal Bacterial Overgrowth: Updates and Clinical Implications. Christine Stubbe, ND, FABNO Small Intestinal Bacterial Overgrowth: Updates and Clinical Implications Christine Stubbe, ND, FABNO Lahnor Powell, ND, MPH Medical Education Specialist - Atlanta Christine Stubbe, ND, FABNO Technical

More information

Nausea and Vomiting in Palliative Care

Nausea and Vomiting in Palliative Care Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction

More information

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people What Is Dyspepsia? Dyspepsia, also known as indigestion, can have multiple symptoms. Feelings of indigestion happen during or after eating. If you have indigestion you might feel: Full during a meal. Painful

More information

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning

More information

14 days for RA (vs steroids)

14 days for RA (vs steroids) 14-21 days for SIBO On chart review, subjects who successfully normalized their breath test had a 66.4 +/- 36.1% improvement in bowel symptoms, compared to 11.9 +/- 22.0% in those who failed to normalize

More information

Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders.

Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders. Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders. SmartPill benefits your practice: Convenient performed right in your office Test standardization Provides direct

More information

The influence of early postoperative enteral feeding and promotility drugs on upper GI tract and gallbladder motility in the critical care setting

The influence of early postoperative enteral feeding and promotility drugs on upper GI tract and gallbladder motility in the critical care setting The influence of early postoperative enteral feeding and promotility drugs on upper GI tract and gallbladder motility in the critical care setting Alan Šustić, MD, PhD Dept. of Anesthesiology and ICU Univ.

More information

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia Lana Bistritz MD FRCPC Royal Alexandra Hospital GI Update 2016 Disclosures I have no relevant financial disclosures I will be discussing off

More information

Approach to Nausea & Vomi2ng

Approach to Nausea & Vomi2ng Approach to Nausea & Vomi2ng Med 3 Seminar 2017 Dr. Robin Grant Division of Pallia2ve Medicine robin.grant@nshealth.ca Why nausea and vomi2ng? Pain 80-90+ % Fa2gue / asthenia 75-90% Cons2pa2on 70% Dyspnea

More information

Restless Leg Syndrome The Role of SIBO and Inflammation

Restless Leg Syndrome The Role of SIBO and Inflammation Lincoln College of Postprofessional, Graduate and Continuing Education Restless Leg Syndrome The Role of SIBO and Inflammation Instructor: Leonard Weinstock, MD, FACG Faculty and Instructors representing

More information

Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment?

Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment? Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment? Brian E. Lacy, MD, PhD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology & Hepatology

More information

Pathophysiology/Etiology As with most diseases in the veterinary

Pathophysiology/Etiology As with most diseases in the veterinary VETTALK Volume 15, Number 04 American College of Veterinary Pharmacists THE HARD TRUTH ABOUT PROKINETIC MEDICATION USE IN PETS Introduction The moving topic of this Vet Talk newsletter will be prokinetic

More information

IBS. Patient INFO. A Guide to Irritable Bowel Syndrome

IBS. Patient INFO. A Guide to Irritable Bowel Syndrome Patient INFO IBS A Guide to Irritable Bowel Syndrome The information provided by the AGA Institute is not medical advice and should not be considered a replacement for seeing a medical professional. About

More information

GASTROPARESIS. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis

GASTROPARESIS. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis GASTROPARESIS C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis Symptom Definitions Nausea: a subjective feeling of wanting to vomit Vomiting: forceful expulsion of gastroduodenal

More information

Is one of the most common chronic disorders. causing patients to seek medical treatment.

Is one of the most common chronic disorders. causing patients to seek medical treatment. ILOs After this lecture you should be able to : Define IBS Identify causes and risk factors of IBS Determine the appropriate therapeutic options for IBS Is one of the most common chronic disorders causing

More information

Use of Prokinetic Agents in Intensive Care Medicine - What is Evidence Based? Dr Martin Sterba PhD EDIC CICM TWH ICU, NSW, Australia

Use of Prokinetic Agents in Intensive Care Medicine - What is Evidence Based? Dr Martin Sterba PhD EDIC CICM TWH ICU, NSW, Australia Use of Prokinetic Agents in Intensive Care Medicine - What is Evidence Based? Dr Martin Sterba PhD EDIC CICM TWH ICU, NSW, Australia Ostrava Ostrava Wollongong Wollongong Wollongong Prokinetics and EBM

More information

IBS Irritable Bowel syndrome Therapeutics II PHCL 430

IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Salman Bin AbdulAziz University College Of Pharmacy IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Email:- ahmedadel.pharmd@gmail.com Ahmed A AlAmer PharmD R.S is 32-year-old woman experiences intermittent

More information

Outline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments

Outline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments Chronic Dyspepsia Eamonn M M Quigley MD FRCP FACP MACG FRCPI Lynda K and David M Underwood Center for Digestive Disorders Houston Methodist Hospital Houston, Texas Outline Definition (s) Epidemiology Pathophysiology

More information

Propulsion and mixing of food in the alimentary tract Chapter 63

Propulsion and mixing of food in the alimentary tract Chapter 63 Propulsion and mixing of food in the alimentary tract Chapter 63 Types of GI movements: Propulsive movement-peristalsis Propulsion: controlled movement of ingested foods, liquids, GI secretions, and sloughed

More information

IBS - Definition. Chronic functional disorder of GI generally characterized by:

IBS - Definition. Chronic functional disorder of GI generally characterized by: IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987

More information

Functional Dyspepsia

Functional Dyspepsia Functional Dyspepsia American College of Gastroenterology Boston Massachusetts, June 2015 Brian E. Lacy, PhD, MD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology

More information

Gastroparesis. - Recent advances in the pathophysiology and treatment -

Gastroparesis. - Recent advances in the pathophysiology and treatment - ICDM 2015 Gastroparesis - Recent advances in the pathophysiology and treatment - Department of Internal Medicine, College of Medicine, St. Paul s hospital, The Catholic University of Korea, Seoul, Korea

More information

Dr. Patsy Smyth, FNP-BC

Dr. Patsy Smyth, FNP-BC Dr. Patsy Smyth, FNP-BC Gastroparesis literally translated means stomach paralysis. Gastroparesis is a syndrome characterized by delayed gastric emptying in absence of mechanical obstruction of the stomach.

More information

STRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA)

STRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA) STRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA) DEFINITION OF ENTERAL FEEDING INTOLERANCE Gastrointestinal feeding intolerance are usually defined as: High gastric

More information

Hompes Method. Practitioner Training Level II. Lesson Eight Part 1C SIBO Protocols

Hompes Method. Practitioner Training Level II. Lesson Eight Part 1C SIBO Protocols Hompes Method Practitioner Training Level II Lesson Eight Part 1C SIBO Protocols Health for the People Ltd not for reuse without expressed permission Hompes Method is a trading name of Health For The People

More information

Digestion: Soothing Irritable Bowel

Digestion: Soothing Irritable Bowel Digestion: Soothing Irritable Bowel Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one on one relationship with a qualified health care professional

More information

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many

More information

Refractory GERD : case presentation and discussion

Refractory GERD : case presentation and discussion Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018 How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81%

More information

Copy right protected Page 1

Copy right protected Page 1 DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.

More information

Definition, Pathogenesis, and Management of That Cursed Dyspepsia

Definition, Pathogenesis, and Management of That Cursed Dyspepsia Clinical Gastroenterology and Hepatology 2018;16:467 479 Definition, Pathogenesis, and Management of That Cursed Dyspepsia Pramoda Koduru, Malcolm Irani, and Eamonn M. M. Quigley IM F1 김영기 Dyspepsia Umbrella

More information

What is Irritable Bowel Syndrome (IBS)?

What is Irritable Bowel Syndrome (IBS)? What is Irritable Bowel Syndrome (IBS)? Irritable bowel syndrome (IBS) is a health issue found in your intestines (gut). IBS can cause symptoms such as: Belly pain. Cramping. Gas. Bloating (or swelling)

More information

PRUCAPLA Tablets (Prucalopride)

PRUCAPLA Tablets (Prucalopride) Published on: 2 May 2018 PRUCAPLA Tablets (Prucalopride) Composition PRUCAPLA 1 mg Each film coated tablet contains: Prucalopride succinate equivalent to Prucalopride 1 mg Excipients. q. s. Color: Titanium

More information

Are adhesions the missing link" in unresolved SIBO? Financial Disclosures

Are adhesions the missing link in unresolved SIBO? Financial Disclosures Are adhesions the missing link" in unresolved SIBO? Larry Wurn, LMT, Research Chair Clear Passage Physical Therapy Belinda Wurn, PT, Clinical Director Financial Disclosures Owner, Clear Passage Physical

More information

Gastrointestinal Physiology. Intensive Care Training Program Radboud University Nijmegen Medical Centre

Gastrointestinal Physiology. Intensive Care Training Program Radboud University Nijmegen Medical Centre Gastrointestinal Physiology Intensive Care Training Program Radboud University Nijmegen Medical Centre Content Gastrointestinal blood flow Portal hypertension Motility disorders Specific metabolic disorders

More information

Pharmacy Benefit Determination Policy

Pharmacy Benefit Determination Policy Policy Subject: Opioid Induced Constipation Policy Number: SHS PBD11 Category: GI Agents Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS

More information

Posttest Questions and Rationale PDF document for posting.

Posttest Questions and Rationale PDF document for posting. Understanding Medical Foods in the Pharmacy Posttest Questions and Rationale PDF document for posting. 1. A physician asks a pharmacist to supply CerefolinNAC for a patient who has mild cognitive impairment

More information

MANAGEMENT OF VISCERAL PAIN

MANAGEMENT OF VISCERAL PAIN MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal

More information

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort

More information

SIBO

SIBO SIBO What is it? Small Intestinal Bowel Overgrowth A chronic bacterial infection of the small intestine Caused by bad bacteria such as E Coli and Clostridium migrating to the small intestine There is not

More information

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium

More information

A Guide to Help You Reduce and Stop Using Tobacco

A Guide to Help You Reduce and Stop Using Tobacco Let s Talk Tobacco A Guide to Help You Reduce and Stop Using Tobacco Congratulations for taking this first step towards a healthier you! 1-866-710-QUIT (7848) albertaquits.ca It can be hard to stop using

More information

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal

More information

Digestion. Absorption and Transport. Digestion. Digestion. (Chapter 3) Your GI tract is like a tube!

Digestion. Absorption and Transport. Digestion. Digestion. (Chapter 3) Your GI tract is like a tube! Digestion Absorption and Transport Digestion the process of breaking down food into its basic components so they can be absorbed CHO, fat, pro are hydrolysed Vits, mins, water aren t (Chapter 3) Digestion

More information

Pharmacology. -Alia Shatnawi

Pharmacology. -Alia Shatnawi Pharmacology -3 -Alia Shatnawi Gastroesophageal reflux disease (GERD): a digestive disorder that affects the lower esophageal sphincter, characterized by reflux of acids from the stomach to the esophagus

More information

Overview of digestion

Overview of digestion Key concepts in Digestion. Overview of digestion introduction to the GI system Prof. Barry Campbell Cellular & Molecular Physiology e-mail: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl DIGESTION

More information

Enhanced Recovery after Surgery - A Colorectal Perspective. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Enhanced Recovery after Surgery - A Colorectal Perspective. R Sim Centre for Advanced Laparoscopic Surgery, TTSH Enhanced Recovery after Surgery - A Colorectal Perspective R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus resolves Opioid

More information

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS? 1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will

More information

Hompes Method. Practitioner Training Level II. Lesson Eight The 4Rs Part B (ii) Restore

Hompes Method. Practitioner Training Level II. Lesson Eight The 4Rs Part B (ii) Restore Hompes Method Practitioner Training Level II Lesson Eight The 4Rs Part B (ii) Restore Health for the People Ltd not for reuse without expressed permission Hompes Method is a trading name of Health For

More information

Disclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview

Disclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview Gastroparesis: Are We Moving On? Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, MA Disclosures Consultant Alkermes, Allergan, Forest,

More information

Today- 90 minutes! Sustainable commitment - what is that and and why is it a challenge? Early symptoms and vulnerability.

Today- 90 minutes! Sustainable commitment - what is that and and why is it a challenge? Early symptoms and vulnerability. Today- 90 minutes! Sustainable commitment - what is that and and why is it a challenge? Early symptoms and vulnerability Restoration Remaining healthy - Strategies Student commitment challenges - Stress-vulnerability

More information

Emerging Treatments for IBS-C and Clinical Trial Endpoints

Emerging Treatments for IBS-C and Clinical Trial Endpoints Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current

More information

International Congress of the Italian Association of Companion Animal Veterinarians

International Congress of the Italian Association of Companion Animal Veterinarians www.ivis.org International Congress of the Italian Association of Companion Animal Veterinarians 2 - May, 201 Rimini, Italy Next Congress : SCIVAC International Congress Ma -, 201 -, Italy Reprinted in

More information

Dr. Melissa Kagarise, PA C

Dr. Melissa Kagarise, PA C Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of

More information

Digestive Health Symptomatic Relief Suggestions

Digestive Health Symptomatic Relief Suggestions Digestive Health Symptomatic Relief Suggestions Here are a list of suggestions in case you end up with constipation, bloating and stomach pain, diarrhea and/or indigestion/acid reflux. These are some great

More information

Objectives. Pain Types Brief Review. Referred Pain. Chronic/Recurrent Abdominal Pain 1/12/2017. I have no conflicts of interest to disclose

Objectives. Pain Types Brief Review. Referred Pain. Chronic/Recurrent Abdominal Pain 1/12/2017. I have no conflicts of interest to disclose Joshua D Noe, MD Associate Professor of Pediatric Gastroenterology Hepatology and Nutrition Medical College of Wisconsin I have no conflicts of interest to disclose Objectives Differentiate functional

More information

Straight Talk on. Women s GI Health. By Judith Reichman, MD, women s health specialist. A new nationwide health campaign for women over age 40

Straight Talk on. Women s GI Health. By Judith Reichman, MD, women s health specialist. A new nationwide health campaign for women over age 40 Straight Talk on Women s GI Health By Judith Reichman, MD, women s health specialist A new nationwide health campaign for women over age 40 welcome! As a gynecologist for more than 25 years, I have seen

More information

Opioid-Induced Constipation

Opioid-Induced Constipation Objectives Opioid-Induced Constipation Brianna Jansma, PharmD Alex Smith, PharmD Megan Robinson, PharmD Summarize epidemiology of opioid-induced constipation (OIC) Understand opiates effects on the gastrointestinal

More information

Gastroparesis: Diagnosis and Management

Gastroparesis: Diagnosis and Management Gastroparesis: Diagnosis and Management Rodica Pop-Busui MD, PhD Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI Disclosures Astra Zeneca Research

More information

EDUCATION PRACTICE. Management of Delayed Gastric Emptying. Clinical Scenario. The Problem. Management Strategies and Supporting Evidence

EDUCATION PRACTICE. Management of Delayed Gastric Emptying. Clinical Scenario. The Problem. Management Strategies and Supporting Evidence CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:642 646 EDUCATION PRACTICE Management of Delayed Gastric Emptying FRANK K. FRIEDENBERG and HENRY P. PARKMAN Temple University Hospital, Philadelphia, Pennsylvania

More information

Amyloidosis & the GI Tract

Amyloidosis & the GI Tract Amyloidosis & the GI Tract John O. Clarke, M.D. Director, Esophageal Program Clinical Associate Professor of Medicine Stanford University john.clarke@stanford.edu 2017 Topics to cover 1) Patterns of GI

More information

Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome

Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome Anthony Lembo, M.D. Associate Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School What is the general

More information

Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus

More information

Reflux of gastric contents, particularly acid, into the esophagus

Reflux of gastric contents, particularly acid, into the esophagus Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

More information

What part of the gastrointestinal (GI) tract is composed of striated muscle and smooth muscle?

What part of the gastrointestinal (GI) tract is composed of striated muscle and smooth muscle? CASE 29 A 34-year-old man presents to his primary care physician with the complaint of increased difficulty swallowing both solid and liquid foods. He notices that he sometimes has more difficulty when

More information

Pharmacotherapy for IBS

Pharmacotherapy for IBS Pharmacotherapy for IBS Brooks D. Cash, M.D., FACG Chief, Gastroenterology Professor of Medicine University of South Alabama Director, GI Physiology, USA Medical Center Mobile, AL Disclosures I have served

More information

solvingleakygut.com Welcome to the 5 Day Constipation Plan

solvingleakygut.com Welcome to the 5 Day Constipation Plan solvingleakygut.com Welcome to the 5 Day Constipation Plan The Goals of this 5 Day Constipation Protocol: 1. Significantly improve your stool frequency and quality (The final goal is 1-3 bowel movements

More information

Heartburn. Understanding and Treating. Heal n Cure For appointments call

Heartburn. Understanding and Treating. Heal n Cure For appointments call A C P S P E C I A L R E P O R T Understanding and Treating Heartburn What is Heartburn? It begins as a burning pain in the middle of your chest, behind the breastbone, often after a big meal. The burning

More information

Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director

Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director Symptom Management Nausea & Vomiting Thomas McKain, MD, ABFM, ABHPM Medical Director Mr. Jones has nausea and vomiting. May I initiate Compazine from the Comfort Pak? Objectives 1. Delineate the Differential

More information

Pediatric Intake Paperwork. Personal History

Pediatric Intake Paperwork. Personal History Pediatric Intake Paperwork Child s Name: Date: Address: City: Zip: Cell Phone: Work Phone: Email: Date of Birth: Social Security Number: Your occupation: Your employer: Whom to contact in case of emergency?

More information

Medication Safety Presentation

Medication Safety Presentation Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?

More information

Innovative Management of Pain Through Compounding. Shawn Needham R.Ph.

Innovative Management of Pain Through Compounding. Shawn Needham R.Ph. Innovative Management of Pain Through Compounding Shawn Needham R.Ph. Disclosure Shawn Needham is a compounding pharmacist and does have interest in a compounding pharmacy Compounded pharmaceuticals are

More information

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure: David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical

More information

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet Page 1 of 6 Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet What type of drug is it? BuTrans transdermal patches

More information

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35. An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology

More information

Disclosures. IPF Medications: Practical Experience. Prednisone, Azathioprine, N acyetylcysteine. Case 1. Brett Ley, MD, MAS Assistant Professor, UCSF

Disclosures. IPF Medications: Practical Experience. Prednisone, Azathioprine, N acyetylcysteine. Case 1. Brett Ley, MD, MAS Assistant Professor, UCSF IPF Medications: Practical Experience Disclosures Received speakers bureau honorarium from Roche/Genentech (makers of pirfenidone). Brett Ley, MD, MAS Assistant Professor, UCSF 67 y/o man 1 year cough

More information

Recent advances in pharmacological treatment of irritable bowel syndrome

Recent advances in pharmacological treatment of irritable bowel syndrome Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v20.i27.8867 World J Gastroenterol 2014 July 21; 20(27): 8867-8885 ISSN 1007-9327 (print)

More information

DOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the

DOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the DOMPERIDONE BNF 4.6 Class: Prokinetic anti-emetic. Indications: Nausea and vomiting, dysmotility dyspepsia, gastro-oesophageal reflux. Pharmacology Domperidone is a dopamine type 2-receptor antagonist.

More information

Peptic Ulcer Disease Update

Peptic Ulcer Disease Update Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following

More information

Management of Gastroparesis

Management of Gastroparesis Management of Gastroparesis Bible Class Jan Hendrik Niess As published in Am J Gastroenterol. 2013 Jan;108(1):18-37 What is the definition of gastroparesis? What are cardinal symptoms of gastroparesis?

More information

Vomiting Approach to diagnosis

Vomiting Approach to diagnosis Vomiting Approach to diagnosis By Dr. Sahar El-Gharabawy Associate professor of internal medicine Hepato-gastroenterology Unit )SMH ) Mansoura University Definitions: Nausea: Feeling "sick to the stomach",

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

DESCRIPTION Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine.

DESCRIPTION Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. BETHANECHOL CHLORIDE TABLETS, USP 5 mg, 10 mg, 25 mg and 50 mg Rx only DESCRIPTION Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related

More information

Diabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017

Diabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017 Diabetic Gastroparesis Evan M. Klass, MD, FACP February 16, 2017 Scope of the problem The disorder can affect any part of the GI tract Although 10-20% of the general population suffer from functional GI

More information

THE ROLE OF INTEGRATIVE HEALTH IN IBD CARE

THE ROLE OF INTEGRATIVE HEALTH IN IBD CARE THE ROLE OF INTEGRATIVE HEALTH IN IBD CARE Maria R. Mascarenhas February 2018 1 OBJECTIVES What is Integrative Health? How often is it used in patients in the US and in patients with IBD? What are the

More information

PATIENT CASE HISTORY. General Health Medications Allergies

PATIENT CASE HISTORY. General Health Medications Allergies OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in

More information

Nausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA

Nausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA Nausea & Vomiting Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA Prevalence prevalence varies *, systemic review 2007 : overall prevalence : nausea 30%, vomiting 20% in last 1-2 weeks of life : nausea

More information